Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2023-04-28 2023-03-24
Drug Identification Number 02487020 02487020
Brand name ENGERIX-B ENGERIX-B
Common or Proper name Hepatitis B vaccine (recombinant) Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS B SURFACE ANTIGEN HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG 10MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1s 1s
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-03-06 2023-03-06
Estimated end date 2023-05-01 2023-05-01
Actual end date 2023-04-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited supply available for public programs. Supply unavailable for the private market. Limited supply available for public programs. Supply unavailable for the private market.
Health Canada comments